Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Article in Russian | MEDLINE | ID: mdl-25345627

ABSTRACT

OBJECTIVE: Unfortunately, nowadays there are no reliable ways to predict the outcomes of the conservative treatment in patients with dorsopathies. Otherwise, we could identify patients that demand intensive treatment including therapeutic blockades. We approbated and modified a method for assessment of radicular latency duration in patients with lumbosacral radiculopathies to evaluate its diagnostic value and the possibility of using in monitoring of effectiveness of conservative treatment. MATERIAL AND METHODS: We studied the effectiveness of conservative treatment in 60 patients with lumbosacral dorsopathies, including 35 patients manifested with exacerbation of sciatica and 25 patients diagnosed with failed back surgery syndrome (FBSS). RESULTS: There was a definite resistance to treatment in patients with FBSS. The complex management of patients, including neuromidin and epidural glucocorticoid blockades, demonstrated the greater effectiveness. The evaluation of radicular latency duration with neuromidin test turned out to have important predictive value which could be used to stratify treatment of patients with dorsopathies.


Subject(s)
Low Back Pain/diagnosis , Low Back Pain/drug therapy , Lumbosacral Region/physiopathology , Radiculopathy/diagnosis , Radiculopathy/drug therapy , Adult , Aged , Aminoquinolines/therapeutic use , Anesthesia, Epidural , Cholinesterase Inhibitors/therapeutic use , Diagnosis, Differential , Drug Monitoring , Female , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Humans , Low Back Pain/physiopathology , Male , Middle Aged , Nerve Block , Radiculopathy/physiopathology , Young Adult
2.
Article in Russian | MEDLINE | ID: mdl-23994919

ABSTRACT

We studied the efficacy of rheosorbilact, an original infusion drug based on polyalcohols, in the complex therapy of patients with brain ischemia and diabetic neuropathy. Reosorbilact was used intravenously indrops 200-400 ml in day - 20 days. The primary endpoint of the study was the improvement of quality of life assessed with the SF-36 scale after 1 month of treatment. Patients with brain ischemia underwent neuropsychological tests and ultrasound duplex scanning of the carotid and vertebral arteries. In the group of patients with diabetic neuropathy, we evaluated the intensity of pain syndrome with the NRS, blood glucose level and electroneuromyography parameters of low extremities nerves. Some characteristics of acid-base balance were studied in patients of both groups. The results obtained in the study indicate the significant clinical effect of reosorbilact in patients with brain ischemia and diabetic neuropathy.


Subject(s)
Diabetic Neuropathies/drug therapy , Neurology/methods , Thioctic Acid/therapeutic use , Acid-Base Equilibrium , Adult , Aged , Antioxidants/therapeutic use , Diabetic Neuropathies/metabolism , Female , Follow-Up Studies , Humans , Male , Middle Aged , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...